TrivarX (TRI.AX) Stock Price

TrivarX Price

CLOSED
0.01
​
Market closed

Over the last 18 years TrivarX grew revenue by 31.3% annually, reaching 1.13 M AUD. For TrivarX, the net margin of -83.5% is up versus -1,462.4% a few years ago.

TrivarX stock price

Access this data via the Eulerpool API

TrivarX business model & stock analysis

TrivarX Ltd is a AU-based company operating in Health Care Technology industry. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is conducting clinical research, product development and early-stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. The company has launched its consumer mobile application to help measure, monitor, and manage stress, called LUCA. LUCA is a biometric assessment tool that measures sleep stress, activity stress, and cardiac stress that allows consumers to monitor their daily stress levels through their own personal wearable device.

Frequently asked questions about TrivarX

5 analysts currently rate the TrivarX stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the TrivarX share trades at 0.01 EUR (0.01 AUD).

The revenue cannot currently be calculated for TrivarX.

The profit of TrivarX is -8.76 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of TrivarX is currently -0.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the TrivarX stock.

The P/S cannot be calculated for TrivarX currently.

The Eulerpool Quality Score for TrivarX is 2/10.

The ISIN of TrivarX is AU0000300196. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of TrivarX is TRI.AX. The ticker symbol is used to trade TrivarX shares on the stock exchange.

Fair ValueTerminal
0.01 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
Jan 29, 2001
ISIN
AU0000300196
Cusip
Q5922F151
Market capitalization
11.54 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.72
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-54.44 %
Last updated Oct 9, 2026, 5:08 AM

TrivarX Peer Group

TrivarX FIGI

TRI:AU · BBG000BXKW74TRI:AT · BBG000BXKWR2TRI:AH · BBG002F3H5Z4MEBEUR:EO · BBG007NTDRC8MEBEUR:XH · BBG007NTDRG4MEBEUR:XF · BBG007NTDRJ1MEBEUR:XE · BBG007NTDRL8MEBEUR:XJ · BBG007NTDRM7MEBEUR:XL · BBG007NTDRN6MEBEUR:XG · BBG007NTDRP4MEBEUR:XO · BBG007NTDRQ3MEBEUR:XA · BBG007NTDRW6

All fundamentals and in-depth analysis of TrivarX

Our stock analysis for TrivarX stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TrivarX. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.